Douglass Winthrop Advisors LLC Has $1.27 Million Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Douglass Winthrop Advisors LLC lowered its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1.2% in the third quarter, Holdings Channel.com reports. The institutional investor owned 2,589 shares of the medical equipment provider’s stock after selling 32 shares during the quarter. Douglass Winthrop Advisors LLC’s holdings in Intuitive Surgical were worth $1,272,000 as of its most recent SEC filing.

Other large investors also recently made changes to their positions in the company. Ridgewood Investments LLC acquired a new stake in Intuitive Surgical in the 2nd quarter worth approximately $26,000. Godsey & Gibb Inc. raised its position in shares of Intuitive Surgical by 140.0% in the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock valued at $29,000 after purchasing an additional 35 shares during the period. Creekmur Asset Management LLC lifted its stake in shares of Intuitive Surgical by 200.0% in the first quarter. Creekmur Asset Management LLC now owns 63 shares of the medical equipment provider’s stock worth $25,000 after buying an additional 42 shares during the last quarter. LGT Financial Advisors LLC boosted its holdings in shares of Intuitive Surgical by 415.4% during the 2nd quarter. LGT Financial Advisors LLC now owns 67 shares of the medical equipment provider’s stock worth $30,000 after buying an additional 54 shares during the period. Finally, MidAtlantic Capital Management Inc. acquired a new position in Intuitive Surgical in the 3rd quarter valued at $33,000. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Trading Down 0.5 %

NASDAQ ISRG opened at $547.87 on Monday. Intuitive Surgical, Inc. has a 1-year low of $304.50 and a 1-year high of $552.00. The company has a market capitalization of $195.14 billion, a price-to-earnings ratio of 88.08, a PEG ratio of 5.39 and a beta of 1.39. The stock’s 50 day moving average is $504.73 and its two-hundred day moving average is $464.13.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 EPS for the quarter, beating the consensus estimate of $1.24 by $0.32. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. The business had revenue of $2.04 billion for the quarter, compared to analyst estimates of $2.01 billion. On average, analysts predict that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current year.

Analyst Ratings Changes

ISRG has been the subject of a number of research analyst reports. Raymond James boosted their target price on shares of Intuitive Surgical from $500.00 to $540.00 and gave the stock an “outperform” rating in a research report on Monday, October 14th. Redburn Atlantic raised Intuitive Surgical from a “neutral” rating to a “buy” rating and boosted their price objective for the stock from $380.00 to $510.00 in a research report on Friday, August 2nd. Leerink Partners raised their target price on Intuitive Surgical from $489.00 to $502.00 in a report on Thursday, October 17th. Robert W. Baird upped their price target on Intuitive Surgical from $503.00 to $565.00 and gave the stock an “outperform” rating in a report on Thursday, October 17th. Finally, Evercore ISI restated a “cautious” rating on shares of Intuitive Surgical in a research note on Friday, October 18th. One analyst has rated the stock with a sell rating, five have issued a hold rating and fourteen have given a buy rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $524.61.

Insider Activity at Intuitive Surgical

In related news, EVP Robert Desantis sold 188 shares of the firm’s stock in a transaction on Thursday, August 29th. The stock was sold at an average price of $482.21, for a total transaction of $90,655.48. Following the completion of the sale, the executive vice president now directly owns 5,506 shares of the company’s stock, valued at $2,655,048.26. This trade represents a 3.30 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, General Counsel Gary Loeb sold 300 shares of the business’s stock in a transaction on Monday, September 9th. The stock was sold at an average price of $475.00, for a total value of $142,500.00. Following the completion of the transaction, the general counsel now directly owns 1,595 shares in the company, valued at approximately $757,625. This represents a 15.83 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 50,539 shares of company stock valued at $26,112,364 in the last ninety days. Insiders own 0.80% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.